COMMUNIQUÉS West-GlobeNewswire

Intrommune Therapeutics To Present A New Form Of Allergy Treatment At The 2024 American Academy Of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
06/02/2024
New study is the first to evaluate Oral Mucosal Immunotherapy (OMIT) for the treatment of food allergy NEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Intrommune Therapeutics , Inc., a clinical-stage biotechnology company [...]
Spectral AI to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
06/02/2024
DALLAS, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
Linnea SA of Switzerland and Universidade Estadual de Campinas (Unicamp) Brazil announce scientific partnership to promote cannabinoids research
06/02/2024
RIAZZINO, Switzerland, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Linnea SA, a leading global Active Pharmaceutical Ingredients manufacturer with over 40 years of experience and a long-term presence in the Latam area, is pleased [...]
La société suisse Linnea SA et Universidade Estadual de Campinas (Unicamp) Brésil annoncent un partenariat scientifique pour promouvoir la recherche sur les cannabinoïdes
06/02/2024
Riazzino, Suisse, 06 févr. 2024 (GLOBE NEWSWIRE) -- Linnea SA, leader mondial dans la production de Principes Actifs Pharmaceutiques avec plus de 40 ans d’expérience et une présence à long terme en Amérique latine, est [...]
MANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITS
06/02/2024
MangoRx Wants to Keep Fumbles on the Field, Not in the Bedroom, Offering the Losing Team Free MangoRx ED Products for One Year Dallas, Texas, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (Nasdaq: MGRX) (“ [...]
nuEra Cannabis Becomes a Vertically Integrated Illinois Powerhouse with Ieso Acquisition
06/02/2024
The award-winning, family-owned and operated retailer closed a winning deal in the nation’s third-largest cannabis market CHICAGO, Feb. 06, 2024 (GLOBE NEWSWIRE) -- nuEra Cannabis (“nuEra” or “the Company”), a leading [...]
INmune Bio to Participate in Baird’s Biotech Discovery Series Webcast on February 13, 2024
06/02/2024
Boca Raton, Florida, Feb. 06, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company targeting microglial activation and neuroinflammation as a cause of Alzheimer’s [...]
Nudj Health Expands Virtual Cardiac Rehab Services to Patients with Ornish Lifestyle Medicine by Sharecare
06/02/2024
Partnership Allows Physician Groups to Provide Cardiac Rehab to Patients At Home PASADENA, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Nudj Health , a tech-enabled health service that delivers evidence-based mental health [...]
Philips Sounds transform the sound of care, reducing patient monitoring alarm noise by up to 66%
06/02/2024
February 6, 2024 FDA 510(k) clearance of latest Philips IntelliVue patient monitor software helps drive alarm management strategies toward a more peaceful, healing environment for patients and caregivers Amsterdam, the [...]
Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock
06/02/2024
REDWOOD CITY, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a clinical-stage biotechnology company focused on developing novel antibody therapies targeting c-Kit (CD117) [...]
Autonomix Medical, Inc. Receives Ethics Committee Authorization for Proof-of-Concept Human Clinical Study Evaluating Proprietary Ablation Technology for Treatment of Pancreatic Cancer Pain
06/02/2024
First study ever to evaluate radiofrequency (RF) ablation in a transvascular approach to reduce the pain associated with pancreatic cancer On track to commence enrollment in Q1 2024 THE WOODLANDS, TX, Feb. 06, 2024 ( [...]
New Publication Identifies Key Proteins Involved in Amyloid Oligomer Binding and Supports Mechanism of CT1812
06/02/2024
NEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, announced that collaborators at the University [...]
GRANT OF PERFORMANCE SHARE UNITS
06/02/2024
Pursuant to Ambu A/S’ (Ambu) Remuneration Policy, a total of 172,956 Performance Share Units (PSUs) related to Ambu’s long-term incentive programme (LTIP) for 2023/24 have been granted on 6 February 2024 with [...]
Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing
06/02/2024
Bria-Pros+ is based on BriaCell’s next generation personalized immunotherapy platform Bria-Pros+ is capable of activating multiple types of immune cells, including helper T cells, cytotoxic (killer) T cells and natural [...]
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/02/2024
BOSTON, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of [...]
Veru Announces FDA Clearance of IND Application to Initiate Phase 2b Clinical Trial with Enobosarm to Treat Muscle Loss Associated with Weight Loss Drugs
06/02/2024
FDA IND clearance is an important development milestone in advancing enobosarm in combination with GLP-1 drugs for potentially higher quality weight loss than has been shown with GLP-1 drug alone Randomized Phase 2b [...]
Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
06/02/2024
HANOVER, MD, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of [...]
Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company
06/02/2024
JUPITER, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company announced it has signed a fully funded [...]
Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer
06/02/2024
-- Seasoned sales and marketing executive with 25 years of experience leading public and private healthcare companies throughout various stages of commercialization will lead commercial launch of FemaSeed -- ATLANTA, [...]

Pages